Longitudinal monitoring of lipase and amylase in adults with type 2 diabetes and obesity: evidence from two phase 3 randomized clinical trials with the once-daily GLP-1 analog liraglutide [poster presentation at Digestive Disease Week 2012]
Safety assessments were conducted from baseline through end-of-study follow-up, and pharmacokinetic and exploratory assessments were performed at prespecified time points, including serial sampling up to 672 h after the final dose
One phase 2 trial looking at whether GLP-1s could reduce the use of opioids in people with opioid use disorder has started recruiting participants
This continuous accessibility ensures patients feel supported and valued, fostering a strong sense of community
The pills contain salcaprozate sodium, which helps protect the active ingredients from stomach acids and allows absorption across the stomach lining, Jaisinghani explains
This reduces the risk of infection